Anaïs Wakx

Anaïs Wakx

Auto-generated profile, based on publicly available information

Anaïs Wakx

UMR CNRS 8038 CiTCoM, Laboratoire de Chimie-Toxicologie Analytique et Cellulaire, Université de Paris, Faculté de Pharmacie de Paris, Paris, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AWAnaïs Wakx
Anaïs Wakx
MNMargaux Nedder
Margaux Nedder
CTCéline Tomkiewicz-Raulet
Céline Tomkiewicz-Raulet
JDJessica Dalmasso
Jessica Dalmasso
ACAudrey Chissey
Audrey Chissey
IFIoana FERECATU
Ioana FERECATU
The human placenta is an organ between the blood of the mother and the fetus, which is essential for fetal development. It also plays a role as a selective barrier against environmental pollutants that may bypass epithelial barriers and reach the placenta, with implications for the outcome of pregnancy. The aryl hydrocarbon receptor (AhR) is one of the most important environmental-sensor transcription factors and mediates the metabolism of a wide variety of xenobiotics. Nevertheless, the identification of dietary and endogenous ligands of AhR suggest that it may also fulfil physiological functions with which pollutants may interfere. Placental AhR expression and activity is largely unknown. We established the cartography of AhR expression at transcript and protein levels, its cellular distribution, and its transcriptional activity toward the expression of its main target genes. We studied the profile of AhR expression and activity during different pregnancy periods, during trophoblasts differentiation in vitro, and in a trophoblast cell line. Using diverse methods, such as cell fractionation and immunofluorescence microscopy, we found a constitutive nuclear localization of AhR in every placental model, in the absence of any voluntarily-added exogenous activator. Our data suggest an intrinsic activation of AhR due to the presence of endogenous placental ligands.

1 June 2018 in Biochimie
Verified
Journal Article
Closed access
JPJulia Petit
Julia Petit
AWAnaïs Wakx
Anaïs Wakx
SGSophie Gil
Sophie Gil
Thierry FournierThierry Fournier
Thierry Fournier
ANAuzeil Nicolas
Auzeil Nicolas
OLOlivier Laprévote
Olivier Laprévote

31 March 2021 in Anatomy & Cell Biology
Verified
Journal Article
Open access
PDF file
EOElodie Olivier
Elodie Olivier
AWAnaïs Wakx
Anaïs Wakx
SFSophie Fouyet
Sophie Fouyet
MDMélody Dutot
Mélody Dutot
PRPatrice RAT
Patrice RAT
Elodie Olivier, Anaïs Wakx, Sophie Fouyet, Mélody Dutot, Patrice Rat. Anat Cell Biol -0001;0:. https://doi.org/10.5115/acb.20.234

20 January 2017 in Journal of Biological Methods
Verified
Journal Article
Open access
PDF file
PRPatrice Rat
Patrice Rat
EOElodie Olivier
Elodie Olivier
CTCaroline Tanter
Caroline Tanter
AWAnaïs Wakx
Anaïs Wakx
MDMélody Dutot
Mélody Dutot
The YO-PRO-1 assay provides a quantitative estimation of P2X7 receptor activation. P2X7 receptor is associated to pathological conditions including infectious, inflammatory, neurological, musculoskeletal disorders, pain and cancer. Most primary cells and cell lines from diverse origin may be used thanks to the ubiquitous distribution of P2X7 receptor. To study the activation of P2X7 receptor by chemicals or biological agents, we established a microplate-based cytometry protocol to accurately and rapidly quantify the activation of P2X7 receptor that leads to the formation of large pores in cell membranes. The YO-PRO-1 assay is based on the ability of cells to incorporate and bind YO-PRO-1 dye to DNA after activation of P2X7 receptor through pore formation. Cells are seeded in 96-well plates and incubated with the compound being tested for the appropriate time. The microplate is then incubated for 10 min with YO-PRO-1 staining solution. After the 10 min staining time, fluorescence signal is read using a microplate reader in 1 min. This procedure is easier and requires less handling steps than flow cytometry. 96-well plate based YO-PRO-1 assay is a reproducible and fast method to study both P2X7 receptor activation by toxic agents at subnecrotic concentrations and P2X7 receptor inhibition by antagonists.

14 October 2015 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Open access
PDF file
AWAnaïs Wakx
Anaïs Wakx
MDMélody Dutot
Mélody Dutot
FMFrance Massicot
France Massicot
FMFrédéric Mascarelli
Frédéric Mascarelli
GLG. Astrid Limb
G. Astrid Limb
PRPatrice RAT
Patrice RAT
Retinal Müller glial cells have already been implicated in age-related macular degeneration (AMD). AMD is characterized by accumulation of toxic amyloid-β peptide (Aβ); the question we raise is as follows: is P2X7 receptor, known to play an important role in several degenerative diseases, involved in Aβ toxicity on Müller cells? Retinal Müller glial cells were incubated with Aβ for 48 h. Cell viability was assessed using the alamarBlue assay and cytotoxicity using the lactate dehydrogenase (LDH) release assay. P2X7 receptor expression was highlighted by immunolabeling observed on confocal microscopy and its activation was evaluated by YO-PRO-1 assay. Hoechst 33342 was used to evaluate chromatin condensation, and caspases 8 and 3 activation was assessed using AMC assays. Lipid formulation rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) used in Age-Related Eye Disease Study 2 was incubated on cells for 15 min prior to Aβ incubation. For the first time, we showed that Aβ induced caspase-independent apoptosis through P2X7 receptor activation on our retinal model. DHA and EPA are polyunsaturated fatty acids recommended in food supplement to prevent AMD. We therefore modulated Aβ cytotoxicity using a lipid formulation rich in DHA and EPA to have a better understanding of the results observed in clinical studies. We showed that fish oil rich in EPA and DHA, in combination with a potent P2X7 receptor antagonist, represents an efficient modulator of Aβ toxicity and that P2X7 could be an interesting therapeutic target to prevent AMD.

1 April 2016 in Toxicology in Vitro
Verified
Journal Article
Closed access
AWAnaïs Wakx
Anaïs Wakx
ARAnne Regazzetti
Anne Regazzetti
DDDelphine Dargère
Delphine Dargère
NANicolas Auzeil
Nicolas Auzeil
SGSophie Gil
Sophie Gil
PRPatrice RAT
Patrice RAT